lymphoma, follicular
Showing 1 - 25 of 65
Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)
Not yet recruiting
- Lymphoma, Non-Hodgkin
- +4 more
-
Birmingham, United Kingdom
- +5 more
Sep 18, 2023
People Living With HIV Treated With CD19-directed CAR T Cell
Active, not recruiting
- Leukemia
- +9 more
-
Philadelphia, PennsylvaniaPennsylvania Hospital
Mar 29, 2023
Mycosis Fungoides of Skin (Diagnosis), Cutaneous T-cell Lymphoma, Non Hodgkin Lymphoma Trial in Cleveland (Med-Jet Injector,
Not yet recruiting
- Mycosis Fungoides of Skin (Diagnosis)
- +5 more
- Med-Jet Injector
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023
Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States (JCAR017, Durvalumab,
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- JCAR017
- +7 more
-
Duarte, California
- +17 more
Jan 13, 2023
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)
Recruiting
- Acute Lymphoblastic Leukemia
- +12 more
-
Tucson, ArizonaThe University of Arizona Cancer Center
Dec 13, 2022
Lymphoma, Follicular, Follicular Lymphoma Trial in Saint Louis (Mosunetuzumab, Polatuzumab vedotin)
Recruiting
- Lymphoma, Follicular
- Follicular Lymphoma
- Mosunetuzumab
- Polatuzumab vedotin
-
Saint Louis, MissouriWashington University School of Medicine
Nov 14, 2022
Long-term Ovarian Fertility in Patients Treated for Lymphoma.
Not yet recruiting
- Lymphoma, Follicular
- (no location specified)
Nov 7, 2022
Lymphoma, Follicular, Lymphoma, Mantle-Cell, Marginal Zone Lymphoma Trial in United States (ADI-001, Fludarabine,
Recruiting
- Lymphoma, Follicular
- +5 more
- ADI-001
- +2 more
-
Stanford, California
- +6 more
Oct 19, 2022
Allogeneic Gamma Delta (?d) CAR T Cells
Enrolling by invitation
- Lymphoma, Follicular
- +5 more
- ADI-001
-
Stanford, California
- +4 more
Jun 7, 2022
Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular Trial in United States
Recruiting
- Lymphoma, Non-Hodgkin
- +3 more
-
Hot Springs, Arkansas
- +12 more
Apr 14, 2022
Follicular Lymphoma, Lymphoma, Follicular Trial in United States (Zevalin Therapeutic Regimen, R-CVP)
Terminated
- Follicular Lymphoma
- Lymphoma, Follicular
- Zevalin Therapeutic Regimen
- R-CVP
-
Jacksonville, Florida
- +5 more
Dec 16, 2021
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States
Completed
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- +5 more
- Hematopoietic Umbilical Cord Blood Stem Cell Transplantation
- GVHD prophylaxis
-
Duarte, California
- +15 more
Nov 2, 2021
Lymphoma, Non-Hodgkin, Lymphoma, Large B-cell, Diffuse, Lymphoma, Follicular Trial in Canada, Germany, United States (TAK-659,
Completed
- Lymphoma, Non-Hodgkin
- +2 more
-
Birmingham, Alabama
- +14 more
Aug 23, 2021
NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)
Completed
- NHL
- +17 more
- veltuzumab
-
Savannah, Georgia
- +4 more
Aug 12, 2021
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +5 more
- Rituximab
- +2 more
-
Providence, Rhode IslandRhode Island Hospital and The Miriam Hospital
Jul 19, 2021
Non-Hodgkin Lymphoma, Burkitt's Lymphoma, Chronic Lymphocytic Leukemia Trial in Italy, United Kingdom, United States (ADCT-402)
Completed
- Non-Hodgkin Lymphoma
- +8 more
-
La Jolla, California
- +10 more
Apr 27, 2021
Lymphoma, Follicular Trial in United States (Bendamustine, Rituximab, Y-90 ibritumomab)
Lymphoma, Follicular, Lymphoma, Low-Grade, Lymphoma, Intermediate-Grade Trial in Munich (procedure, drug, other)
Active, not recruiting
- Lymphoma, Follicular
- +2 more
- FCM
- +3 more
-
Munich, GermanyGerman Low Grade Study Group (Glsg)
May 6, 2021
REVLIMID® Treatment of IPSS Low- or Intermediate-1-risk
Recruiting
- Myelodysplastic Syndromes
- +2 more
-
Anyang, Korea, Republic of
- +12 more
Apr 6, 2021
Study of Lymphoma in Asia
Completed
- Lymphoma, Follicular
- +5 more
-
Hexi District, China
- +3 more
Nov 24, 2020
Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (OT-82 Dose Escalation, OT-82 Dose Expansion)
Recruiting
- Lymphoma
- +6 more
- OT-82 Dose Escalation
- OT-82 Dose Expansion
-
Birmingham, Alabama
- +7 more
Oct 22, 2020